title: In vitro inhibition of heparin-induced platelet aggregation in plasma from patients with HIT by SR 121566, a newly developed Gp IIb/IIIa antagonist.
authors.forename: J P
authors.initials: JP
authors.lastname: Hérault
authors.forename: A
authors.initials: A
authors.lastname: Lalé
authors.forename: P
authors.initials: P
authors.lastname: Savi
authors.forename: A M
authors.initials: AM
authors.lastname: Pflieger
authors.forename: J M
authors.initials: JM
authors.lastname: Herbert
mesh_terms: D001596:Benzylamines; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010880:Piperidines; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013844:Thiazoles; D013921:Thrombocytopenia / Q000097:blood* / Q000139:chemically induced
chemical_list: D001596:Benzylamines; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; C106774:SR 121566; D013844:Thiazoles; D006493:Heparin